J9211 Idarubicin - CanMED: HCPCS

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Medication Information

CanMED: HCPCS

Generic Name:

Idarubicin

Brand Name:

Idamycin

Strength:

5 mg

HCPCS:

J9211

SEER*Rx Category:

Chemotherapy

Major Drug Class:

Antitumor Antibiotic

Minor Drug Class:

Anthracycline

Oral (Y/N):

No

FDA Approval Year:

1990

FDA Discontinuation Year:

CMS Effective Date:

Jan. 1, 1993

CMS Discontinuation Date:

Status:

In Use